Parkman Healthcare Partners LLC Quanterix Corp Transaction History

Parkman Healthcare Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$12.26 - $23.78 $3,248 - $6,301	265 Added 0.15%	176,377 $2.33 Million
Q1 2024 May 15, 2024	BUY	$21.9 - $28.28 $651,437 - $841,216	29,746 Added 20.32%	176,112 $4.15 Million
Q4 2023 Feb 14, 2024	BUY	$19.54 - $28.66 $1.35 Million - $1.99 Million	69,279 Added 89.87%	146,366 $4 Million
Q3 2023 Nov 14, 2023	BUY	$21.15 - $27.96 $569,844 - $753,326	26,943 Added 53.73%	77,087 $2.09 Million
Q2 2023 Aug 11, 2023	BUY	$11.16 - $23.65 $559,607 - $1.19 Million	50,144 New	50,144 $1.13 Million
Q1 2022 May 13, 2022	SELL	$23.26 - $42.41 $465,200 - $848,199	-20,000 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$37.54 - $57.51 $750,800 - $1.15 Million	20,000 New	20,000 $848,000

157

33.2M

30.6K

25.1K

Ticker QTRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 36,987,600
Market Cap $348M
Description
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.